Accession Number:

ADA101911

Title:

Federal Drug Development Programs.

Descriptive Note:

Corporate Author:

GENERAL ACCOUNTING OFFICE WASHINGTON DC HUMAN RESOURCES DIV

Personal Author(s):

Report Date:

1981-07-17

Pagination or Media Count:

20.0

Abstract:

The report is divided into two sections Introduction and scope - includes a discussion of Federal controls over development and marketing of drugs and A description of Federal drug development programs - includes 12 programs identified by our study, highlighting the basis for Government involvement, the scope of their activities, the status of drug development in these programs, and some factors to consider in establishing new drug development programs.

Subject Categories:

  • Pharmacology

Distribution Statement:

APPROVED FOR PUBLIC RELEASE